Latest: Q3 2026 · from the cash-flow statements filed with the SEC
Free cash flow$8.5M in Q3 2026 · $37.3M over twelve months
Operating cash flow$12.9M
Capital spending−$4.4M
Free cash flow+$8.5M
Cash / net income1.0×
Cash conversion cycle35 days
Analysis
In Q3 2026, Alto Ingredients generated $12.9M of operating cash flow and spent $4.4M on capital projects, leaving free cash flow of $8.5M. That is $12.7M less than in Q3 2025 ($21.2M).
Over the twelve months to Sep 30, 2026, operating cash flow was $55.1M; the largest uses were other financing ($33.6M), net borrowing (+) / repaid (−) ($17.8M), capital spending ($17.8M); besides operations, cash came from other investing ($6.7M); the cash balance fell by $7.5M.
Operating cash flow was $12.9M against net income of $13.0M — 1.0× profit, roughly in line with earnings. The largest differences: depreciation & amortization +$6.7M, receivables +$3.6M, inventory −$3.0M.
Its cash conversion cycle was 35 days (receivables 24 + inventory 20 − payables 8).
Free cash flow
Operating cash flow less capital spending.Latest (Q3 2026): Operating cash flow $12.9M, Capital spending $4.4M.
Capital allocation, year by year
Over these 5 years operating cash flow totalled $64.6M; the largest uses were capital spending ($99.3M) and net borrowing ($85.0M). Cash-flow statements as filed.
Cash runway and the debt wall
Cash & investments$23.6M
Debt$58.1M
Net debt$34.5M
Due within a year$16.6M
Alto Ingredients funds itself: free cash flow was $37.3M over the last twelve months, and $23.6M of cash and investments stands against $58.1M of debt ($16.6M due within a year, 1.4× covered by cash).
Principal due in each year as disclosed in the annual report, against $23.6M of cash and investments now.
Where the cash came from and went
From profit to cash
Non-cash charges are added back; money tied up in receivables or inventory is subtracted.
Quarter
Receivable days
Inventory days
Payable days
Cash conversion cycle
Q3 2026
24
20
8
35
Q2 2026
24
21
9
36
Q1 2026
23
24
7
40
Q4 2025
22
24
6
40
Q3 2025
21
23
7
38
Q2 2025
26
22
7
40
Q1 2025
25
20
7
37
Q4 2024
21
19
7
33
Every quarter
Quarter
Operating cash flow
Capital spending
Acquisitions
Net borrowing (+) / repaid (−)
Cash drawn (+) / kept (−)
Free cash flow
Q3 2026
$12.9M
−$4.4M
—
—
−$1.7M
$8.5M
Q2 2026
$28.5M
−$10.6M
—
−$13.0M
−$2.3M
$17.9M
Q1 2026
$4.2M
−$909K
—
−$7.0M
$4.0M
$3.3M
Q4 2025
$9.5M
−$1.9M
—
−$16.4M
$7.5M
$7.6M
Q3 2025
$22.8M
−$1.6M
—
—
−$2.6M
$21.2M
Q2 2025
−$848K
−$484K
—
$7.2M
−$3.3M
−$1.3M
Q1 2025
−$18.2M
−$65.0M
−$7.3M
$17.3M
$9.0M
−$83.2M
Q4 2024
−$9.8M
−$1.3M
—
$9.1M
$2.3M
−$11.1M
Alto Ingredients: income statement and cash flow
Alto Ingredients, Q3 2026: revenue $258M (+7% year over year), operating margin 2.7%. The chart follows the revenue to costs, profit and cash.
Read automatically from the company’s XBRL cash-flow statements; quarterly figures for the fourth quarter are the year less the first three. Errors are possible. Not investment advice.